Toth Financial Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Toth Financial Advisory's AZN Position: Q3 2026 in Review
Toth Financial Advisory reduced its AstraZeneca (AZN) stake by 59% in Q3 2026, selling an estimated $3.67K and leaving 15 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #767.
Toth Financial Advisory first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.3K in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Toth Financial Advisory held 15 shares of AstraZeneca worth $2.42K as of Q3 2026.
- Toth Financial Advisory sold 22 AstraZeneca shares in Q3 2026, an estimated $3.67K.
- AstraZeneca made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #767 holding.
- Toth Financial Advisory first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
- Toth Financial Advisory's AstraZeneca position peaked at $7.3K in Q1 2026.
- 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.